61·1 month ago- While bones can regrow themselves when they break, teeth aren’t so lucky, and that leads to millions of people worldwide suffering from some form of edentulism, a.k.a. toothlessness.
- Now, Japanese researchers are moving a promising, tooth-regrowing medicine into human trials—the first patients will be receiving the drug intravenously in September of this year.
- If the trial is successful, the researchers hope the drug will become available for all forms of toothlessness sometime around 2030.